The Omicron (B. 1.1. 529) variant of the severe acute respiratory syndrome Coronavirus 2
(SARS-CoV-2) had an increased rate of spreading among the general population. Although …

Objectives To assess the duration of viable virus shedding and polymerase chain reaction
(PCR) positivity of the SARS-CoV-2 Omicron variant in the upper respiratory tract. Methods …

Background: Omicron had swept the mainland China between December 2022 and January
2023, while SARS-CoV-2 still continued to evolve. To fully prepare for the next wave, it's …

Early COVID-19 treatments can prevent progression to severe disease. However, real-life
data are still limited, and studies are warranted to monitor the efficacy and tolerability of …

The SARS-CoV-2 virus has caused a catastrophic impact on the world for the past 3 years.
The virus has now returned with the emergence of the Omicron (B. 1.1. 529) variant. Within …

Abstract Introduction The SARS-CoV-2 Omicron variant has decreased virulence and
pathogenicity, yet the number of Omicron infections worldwide is unprecedentedly high, with …

The global spread of the Omicron variant strain BA. 5/BF. 7 has led to an increase in
breakthrough infections. The elderly population shows different immune responses after …

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine booster is one
of the most essential strategies against coronavirus disease 2019 (COVID-19) in the era of …

Background: It remains unclear what B cell and humoral responses are mounted by chronic
kidney disease (CKD) patients in response to recombinant and inactivated SARS-CoV-2 …

Background To explore the risk factors of proteinuria in Omicron variant patients and to
construct and verify the risk predictive model. Methods 1091 Omicron patients who were …